Medmix Stock
Medmix Stock price
Key metrics
| Market capitalization | CHF415.23m |
| Enterprise Value | CHF648.23m |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | 26.68 |
| EV/Sales (TTM) EV/Sales | 1.35 |
| P/S ratio (TTM) P/S ratio | 0.87 |
| P/B ratio (TTM) P/B ratio | 0.90 |
| Dividend yield | 4.91% |
| Last dividend (FY23) | CHF0.50 |
Is Medmix a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.
Medmix Stock Analysis
Analyst Opinions
3 Analysts have issued a Medmix forecast:
Analyst Opinions
3 Analysts have issued a Medmix forecast:
Financial data from Medmix
| Jun '24 |
+/-
%
|
||
| Revenue | 480 480 |
1%
1%
|
|
| Gross Profit | 156 156 |
2%
2%
|
|
| EBITDA | 76 76 |
1%
1%
|
EBIT (Operating Income) EBIT | 14 14 |
43%
43%
|
| Net Profit | -1.80 -1.80 |
63%
63%
|
|
In millions CHF.
Don't miss a Thing! We will send you all news about Medmix directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
medmix AG designs, develops and produces delivery devices for the mixing, application and injection of liquids for the healthcare, consumer and industrial end-markets. The firm operates through a number of well-known brands including Mixpac, Transcodent, Cox, MK, Medmix,Haselmeier and Geka. It operates through two business segments: Healthcare and Consumer & Industrial. The Healthcare business segment is divided into the Dental, Drug Delivery and Surgery market segments. The Dental market segment offers mixing and delivery devices for a broad range of applications, such as prosthetics, restorations, anesthetics and aesthetics. The Drug Delivery market segment offers drug delivery devices that are used to inject fertility drugs, growth hormones and to treat niche diabetes indications, osteoporosis and rare diseases. The Surgery market segment offers mixing and delivery devices are used to inject bone cement and to apply hemostatic sealants for internal and external wound treatment during surgical procedures. The Consumer & Industrial segment operates through the Industry and Beauty market segments. The Industry market segment offers dispensers, cartridges and mixers that are used in the construction, transportation (automotive, railways and aerospace), electronics assembly, infrastructure and do-it-yourself industries. The Beauty market segment offers microbrushes that are used for the application of color cosmetics, such as mascara and in other areas, such as skin care, but also in non-beauty-related areas such as cleaning devices for consumer products. The company was founded on September 9, 2021 and is headquartered in Zug, Switzerland.
| Head office | Switzerland |
| CEO | René Willi |
| Employees | 2,658 |
| Website | www.medmix.swiss |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
